Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  14,563 نتائج ل ""COVID-19 Drug Treatment""

فلترة النتائج

إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Australian National Clinical Evidence Taskforce COVID‐19 drug treatment guidelines: challenges of producing a living guideline

Subjects: Evidence-Based Medicine; National Clinical Evidence Taskforce (NCET); Sustainable Development Goals

  • Source: Medical Journal of Australia. 219:197-199

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Effectiveness and safety of azvudine versus nirmatrelvir/ritonavir in hospitalized patients with COVID-19.

  • Authors : Yang J; Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.; Min J

Subjects: Ritonavir*/Ritonavir*/Ritonavir*/therapeutic use ; Ritonavir*/Ritonavir*/Ritonavir*/adverse effects ; COVID-19 Drug Treatment*

  • Source: BMC infectious diseases [BMC Infect Dis] 2025 May 14; Vol. 25 (1), pp. 701. Date of Electronic Publication: 2025 May 14.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Exploring the therapeutic potential of Thymus vulgaris ethanol extract: a computational screening for antimicrobial compounds against COVID-19 induced mucormycosis.

  • Authors : Naveed M; Department of Biotechnology, Faculty of Science and Technology, University of Central Punjab, Lahore, 54000, Pakistan. .; Saleem A

Subjects: Thymus Plant*/Thymus Plant*/Thymus Plant*/chemistry ; Plant Extracts*/Plant Extracts*/Plant Extracts*/pharmacology ; Plant Extracts*/Plant Extracts*/Plant Extracts*/chemistry

  • Source: Scientific reports [Sci Rep] 2025 May 07; Vol. 15 (1), pp. 15906. Date of Electronic Publication: 2025 May 07.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Association of the medication protocols and longitudinal change of COVID-19 symptoms: a hospital-based mixed-statistical methods study.

Subjects: COVID-19 Drug Treatment* ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/diagnosis

  • Source: Journal of biopharmaceutical statistics [J Biopharm Stat] 2025 May; Vol. 35 (3), pp. 386-406. Date of Electronic Publication: 2024 Mar 21.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9200436 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Molecular dynamics simulation and docking studies reveals inhibition of NF-kB signaling as a promising therapeutic drug target for reduction in cytokines storms.

  • Authors : Kumar A; Department of Computational Biology and AI, Kcat Enzymatic Private Limited, #16, Ramakrishnappa Road, Cox Town, Bangalore, 560005, India.; Bharadwaj T

Subjects: Signal Transduction*/Signal Transduction*/Signal Transduction*/drug effects ; NF-kappa B*/NF-kappa B*/NF-kappa B*/metabolism ; NF-kappa B*/NF-kappa B*/NF-kappa B*/antagonists & inhibitors

  • Source: Scientific reports [Sci Rep] 2025 Apr 30; Vol. 15 (1), pp. 15225. Date of Electronic Publication: 2025 Apr 30.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Identification of Significant Mutations in Spike Protein of SARS-CoV-2 Variants of Concern and the Discovery of Potent Inhibitors.

  • Authors : Almakrami M; Department of Pathology and Laboratory Medicine, King Khaled Hospital, Najran 66262, Saudi Arabia.; Bazuqamah M

Subjects: Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/genetics ; Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/chemistry ; Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/antagonists & inhibitors SARS-CoV-2 variants

  • Source: Global health, epidemiology and genomics [Glob Health Epidemiol Genom] 2025 Apr 28; Vol. 2025, pp. 5042190. Date of Electronic Publication: 2025 Apr 28 (Print Publication: Publisher: John Wiley & Sons, Ltd Country of Publication: England NLM ID: 101703450 Publication Model: eCollection Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

EIDD-2801 resists to infection and co-infection of SARS-CoV-2 and influenza virus.

  • Authors : Qian B; Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, 130122, China.; School of Pharmacy, Henan University, Kaifeng, 475004, China.

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/pharmacology ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; Coinfection*/Coinfection*/Coinfection*/drug therapy

  • Source: Virology journal [Virol J] 2025 Apr 28; Vol. 22 (1), pp. 126. Date of Electronic Publication: 2025 Apr 28.Publisher: BioMed Central Country of Publication: England NLM ID: 101231645 Publication Model: Electronic Cited Medium: Internet ISSN: 1743-422X

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Early combined therapy for COVID-19 in immunocompromised patients: a promising approach against viral persistence and drug resistance.

  • Authors : Rotundo S; Department of Medical and Surgical Sciences, 'Magna Graecia' University, Catanzaro, Italy. .; Infectious Diseases Unit, 'San Giovanni di Dio' Hospital, Crotone, Italy. .

Subjects: Immunocompromised Host* ; COVID-19*/COVID-19*/COVID-19*/therapy ; COVID-19*/COVID-19*/COVID-19*/immunology

  • Source: BMC infectious diseases [BMC Infect Dis] 2025 Apr 28; Vol. 25 (1), pp. 616. Date of Electronic Publication: 2025 Apr 28.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Trends in medication use during the COVID-19 pandemic in Quebec, Canada.

  • Authors : Gosselin M; Institut national de santé publique du Québec, Quebec, Canada.; Dubé M

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19 Drug Treatment*; Humans

  • Source: Scientific reports [Sci Rep] 2025 Apr 27; Vol. 15 (1), pp. 14744. Date of Electronic Publication: 2025 Apr 27.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Mitigating fatigue in long COVID patients with MYP plus : a clinical observation.

  • Authors : Choi YJ; Research Center for CFS/ME, Daejeon University Hospital, Daedukdae-ro 176 bun-gil 75, Seo-gu, Daejeon, 35235, Republic of Korea.; Institute of Bioscience & Integrative Medicine, Daejeon University, Daedukdae-ro 176 bun-gil 75, Seo-gu, Daejeon, 35235, Republic of Korea.

Subjects: Fatigue*/Fatigue*/Fatigue*/drug therapy ; Fatigue*/Fatigue*/Fatigue*/etiology ; COVID-19*/COVID-19*/COVID-19*/complications

  • Source: BMC infectious diseases [BMC Infect Dis] 2025 Apr 26; Vol. 25 (1), pp. 611. Date of Electronic Publication: 2025 Apr 26.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  14,563 نتائج ل ""COVID-19 Drug Treatment""